Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03093662 · ClinicalTrials.gov registry record · NA
Preoxygenation With Nasal Cannula and Noninvasive Positive Pressure Ventilation
A NA study of Hypoxia, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03093662: Completed NA study of Hypoxia, sponsored by Brooke Army Medical Center.
NCT03093662 is a NA study of Hypoxia that has completed, run by Brooke Army Medical Center. The registered enrollment target is 37 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03093662, a NA study of Hypoxia, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective randomized cross over study of healthy volunteers comparing end-tidal oxygen concentration among subjects undergoing continuous positive airway pressure ventilation via a noninvasive ventilation (NIV) mask with and without the addition of nasal cannulas.
Primary Outcome
Measured by exhalation into sensor (Maxtec Max-250E)
Conditions Studied
Interventions
- DEVICE Ventilation with nasal cannula
- DEVICE Ventilation without nasal cannula
Study Locations (1)
Texas
- Brooke Army Medical Center - Fort Sam Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-03-02 |
| Est. Completion | 2017-03-09 |
| Phase | NA |
What the finished NCT03093662 record still lists
NCT03093662 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Ventilation with nasal cannula is the first listed.
NCT03093662 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03093662 about?
NCT03093662 is a clinical study titled "Preoxygenation With Nasal Cannula and Noninvasive Positive Pressure Ventilation". This is a prospective randomized cross over study of healthy volunteers comparing end-tidal oxygen concentration among subjects undergoing continuous positive airway pressure ventilation via a noninvasive ventilation (NIV) mask with and without the addition of nasal cannulas.
What is the current status of trial NCT03093662?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-03-02. Estimated completion is 2017-03-09.
What conditions does trial NCT03093662 study?
This clinical trial studies the following conditions: Hypoxia.
What interventions are being tested in trial NCT03093662?
The interventions under investigation include: Ventilation with nasal cannula (DEVICE), Ventilation without nasal cannula (DEVICE).
Who is sponsoring clinical trial NCT03093662?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03093662 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03093662's enrollment target sits among peer trials
37 20th of 39 higher than 20 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
Structural Modification In Supraglottic Airway Device
RECRUITING · NA
-
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI